Alzheimer's drug lecanemab slows cognitive decline but concerns linger | New Scientist | Scooploop

You must enable Javascript to get the most out of Scooploop.

We use the latest technologies to provide the best possible web experience.

Please enable Javascript in your browser to continue.

FAQ
Scooploop Blog

New Scientist

News @SLBroadcast Mod South Bank - 2y
Alzheimer's drug lecanemab slows cognitive decline but concerns linger

The drug lecanemab slowed the rate of cognitive decline among people with early Alzheimer's disease by 27 per cent, compared with placebo in..
https://www.newscientist.com/article/2349153-alzheimers-drug-lecanemab-slows-cognitive-decline-but-concerns-linger/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home

Share on Scooploop

Share on Facebook

Share on Twitter

Share on Linkedin